Actinium Pharmaceuticals Inc. buy quelbe60
Start price
04.08.24
/
50%
€5.68
Target price
04.08.25
-
Performance (%)
-71.36%
End price
18.08.24
€1.63
Summary
This prediction ended on 18.08.24 with a price of €1.63. Massive losses of -71.36% were the result for the BUY prediction by quelbe60. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Actinium Pharmaceuticals Inc. | 4.739% | 4.739% | 1.989% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to quelbe60 what are the pros and cons of Actinium Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by quelbe60 for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
Buy Actinium Pharmaceuticals Inc.
In the thread Trading Actinium Pharmaceuticals Inc.
Stopped prediction by quelbe60 for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.37
12.05.25
12.05.25
-
12.05.26
12.05.26
3.51%
25.05.25
25.05.25
Could be worthwhile Investment >10% per year
